Rational Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,245
| Closed | -$384K | – | 211 |
|
|
2024
Q1 | $384K | Sell |
5,245
-1,087
| -17% | -$83.6K | 0.04% | 101 |
|
|
2023
Q4 | $513K | Buy |
6,332
+3,075
| +94% | +$239K | 0.05% | 88 |
|
|
2023
Q3 | $245K | Buy |
3,257
+1,277
| +64% | +$98.2K | 0.02% | 107 |
|
|
2023
Q2 | $153K | Buy |
1,980
+1,740
| +725% | +$139K | 0.01% | 134 |
|
|
2023
Q1 | $19.9K | Hold |
240
| – | – | ﹤0.01% | 193 |
|
|
2022
Q4 | $20.6K | Hold |
240
| – | – | ﹤0.01% | 169 |
|
|
2022
Q3 | $15K | Hold |
240
| – | – | ﹤0.01% | 177 |
|
|
2022
Q2 | $15K | Buy |
240
+6
| +3% | +$371 | ﹤0.01% | 177 |
|
|
2022
Q1 | $14K | Buy |
+234
| New | +$15K | ﹤0.01% | 188 |
|
|
2020
Q4 | – | Sell |
-1,366
| Closed | -$87K | – | 362 |
|
|
2020
Q3 | $87K | Buy |
1,366
+1,149
| +529% | +$79.7K | 0.04% | 168 |
|
|
2020
Q2 | $17K | Sell |
217
-5,583
| -96% | -$428K | 0.01% | 297 |
|
|
2020
Q1 | $434K | Buy |
5,800
+4,199
| +262% | +$290K | 0.32% | 100 |
|
|
2019
Q4 | $104K | Buy |
1,601
+50
| +3% | +$3.26K | 0.05% | 283 |
|
|
2019
Q3 | $98K | Sell |
1,551
-4,353
| -74% | -$285K | 0.04% | 294 |
|
|
2019
Q2 | $399K | Buy |
5,904
+4,340
| +277% | +$286K | 0.14% | 156 |
|
|
2019
Q1 | $102K | Buy |
1,564
+1,368
| +698% | +$90.9K | 0.03% | 261 |
|
|
2018
Q4 | $12K | Sell |
196
-2,581
| -93% | -$180K | ﹤0.01% | 382 |
|
|
2018
Q3 | $214K | Buy |
2,777
+2,764
| +21,262% | +$209K | 0.05% | 190 |
|
|
2018
Q2 | $1K | Sell |
13
-5
| -28% | -$353 | ﹤0.01% | 466 |
|
|
2018
Q1 | $1K | Buy |
+18
| New | +$1.43K | ﹤0.01% | 492 |
|
|
2017
Q4 | – | Sell |
-2,100
| Closed | -$170K | – | 307 |
|
|
2017
Q3 | $170K | Buy |
+2,100
| New | +$161K | 0.09% | 226 |
|
|
2015
Q3 | $93K | Hold |
943
| – | – | 0.04% | 221 |
|
|
2015
Q2 | $110K | Sell |
943
-94
| -9% | -$10.3K | 0.04% | 210 |
|
|
2015
Q1 | $102K | Sell |
1,037
-218
| -17% | -$22.1K | 0.02% | 224 |
|
|
2014
Q4 | $118K | Buy |
+1,255
| New | +$130K | 0.02% | 252 |
|
|
2013
Q4 | $662K | Sell |
8,809
-4,758
| -35% | -$331K | 0.06% | 321 |
|
|
2013
Q3 | $853K | Buy |
13,567
+2,220
| +20% | +$133K | 0.07% | 334 |
|
|
2013
Q2 | $582K | Buy |
+11,347
| New | +$591K | 0.05% | 367 |
|
Other funds holding GILD
Rational Advisors's GILD Position: Q2 2024 in Review
Rational Advisors sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 5,245 shares — an estimated $384K sold.
Rational Advisors first reported a position in GILD in Q2 2013 and held it in 28 quarters. The position peaked at $853K in Q3 2013. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- Rational Advisors reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
- Rational Advisors sold 5,245 Gilead Sciences shares in Q2 2024, an estimated $384K.
- Rational Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 28 quarters.
- Rational Advisors's Gilead Sciences position peaked at $853K in Q3 2013.
- 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on Rational Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.